Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Prostate Cancer”

875 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 875 results

Testing effectiveness (Phase 2)Study completedNCT02280356
What this trial is testing

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 45
Large-scale testing (Phase 3)Active Not RecruitingNCT03367702
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Who this might be right for
Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology 692
Large-scale testing (Phase 3)Ended earlyNCT00003645
What this trial is testing

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2
Not applicableStudy completedNCT03225222
What this trial is testing

MRI in PROstate Cancer Diagnosis With Prior Risk Assessment

Who this might be right for
Prostate Cancer
Erasmus Medical Center 2,558
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Not applicableActive Not RecruitingNCT06523777
What this trial is testing

PRISM: Patient Experiences With PET Imaging in Prostate Cancer

Who this might be right for
Prostate Cancer
Yale University 350
Not applicableEnrolling By InvitationNCT06424275
What this trial is testing

Prostate Cancer Awareness and Initiative for Screening in the European Union

Who this might be right for
Prostate Cancer
European Association of Urology Research Foundation 20,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03531099
What this trial is testing

Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 108
Not applicableActive Not RecruitingNCT04985565
What this trial is testing

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 12
Not applicableActive Not RecruitingNCT06126172
What this trial is testing

Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

Who this might be right for
Prostate Cancer
Chang Gung Memorial Hospital 125
Testing effectiveness (Phase 2)Study completedNCT01667536
What this trial is testing

Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Who this might be right for
Prostate Cancer
Molecular Insight Pharmaceuticals, Inc. 105
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Testing effectiveness (Phase 2)Active Not RecruitingNCT00859781
What this trial is testing

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 55
Not applicableStudy completedNCT00643994
What this trial is testing

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Who this might be right for
Prostate CancerProstatic CancerProstate Neoplasms+2 more
Accuray Incorporated 379
Not applicableStudy completedNCT04925180
What this trial is testing

Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe

Who this might be right for
Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and SeborrheaHypersexuality in MenSexual Deviations in Men+1 more
Bayer 600
Testing effectiveness (Phase 2)Study completedNCT00345813
What this trial is testing

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 62
Large-scale testing (Phase 3)Study completedNCT04627896
What this trial is testing

Targeted Microwave Focal Therapy

Who this might be right for
Prostate Cancer Stage I
A.O.U. Città della Salute e della Scienza 11
Testing effectiveness (Phase 2)WithdrawnNCT04565496
What this trial is testing

Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
IRCCS San Raffaele
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Next Page